Extramedullary Multiple Myeloma
3 clinical trials · Condition
◉ Watch Extramedullary Multiple Myeloma
| Record | Firm | Date |
|---|---|---|
| A Study of a Fully Human BCMA-targeting CAR (CT103A) Combined With Selinexor in Patients With Relapsed/Refractory Extramedullary Multiple Myeloma (NCT05201118) | Chunrui Li | 2022-01-01 |
Track Extramedullary Multiple Myeloma automatically
Every clearance here is in the API, with alerts when new ones post.